Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis
Authors:
- Valentina AndreozziVAValentina Andreozzi
- Rocco CapuanoRCRocco Capuano
- Sara ScannapiecoSSSara Scannapieco
- Francesca BarraFBFrancesca Barra
- Caterina GiordanoCGCaterina Giordano
- Miriam CaterinoMCMiriam Caterino
- Umberto De MarcaUMUmberto De Marca
- Federico Di FilippoFFFederico Di Filippo
- Maria Di GregorioMGMaria Di Gregorio
- Paolo BaronePBPaolo Barone
- 27 December 2023
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (6) , 2807-2810
Abstract
Introduction Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery. Methods We described two pwMS with history of bariatric surgery who started DMF as DMT. Results The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation. Conclusions Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss.Keywords
This publication has 18 references indexed in Scilit:
- Factors associated with dimethyl fumarate-induced lymphopeniaJournal of the Neurological Sciences, 2019
- Gut microbiota modulates drug pharmacokineticsDrug Metabolism Reviews, 2018
- Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat dietThe Journal of Nutritional Biochemistry, 2018
- Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple SclerosisFrontiers in Neurology, 2018
- Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose TissueJournal of Biological Chemistry, 2017
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patientsMultiple Sclerosis Journal, 2015
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisNew England Journal of Medicine, 2012
- The importance of the gut microbiota after bariatric surgeryNature Reviews Gastroenterology & Hepatology, 2012
- Pharmacokinetic Effects of Bariatric SurgeryAnnals of Pharmacotherapy, 2012
- In vitro pharmacokinetics of anti-psoriatic fumaric acid estersBMC Pharmacology, 2004